CONFERENCE AGENDA
* Agenda & speakers are subject to change
Saturday, September 27, 2025
7:30 AM
Breakfast and Registration*
​
8:00 AM - 8:45 AM
Clinical Deep Dive: Unlocking the Treatment Potential of Rezidffra
Robert Brown, MD
Industry-Sponsored Event (Non-accredited)*
Sponsored by Madrigal Pharmaceuticals
​8:45 AM - 9:15 AM
Break / Visit Exhibits*
​​
9:15 AM - 9:20 AM
Program Overview
​​
Session I
9:20 AM–9:40 AM
Comprehensive Update on Inflammatory Bowel Disease (IBD)
David Hudesman, MD
​​
9:40 AM–10:00 AM
Primary Biliary Cholangitis Review
Sonal Kumar, MD, MPH
​
10:00 AM–10:20 AM
Update on Viral Hepatitis in 2025
Nancy Reau, MD
​
10:20 AM - 10:35 AM
Panel Discussion / Q&A
​
10:35 AM - 10:50 AM
Break / Visit Exhibits*
​
Session II
10:50 AM - 11:10 AM
IBD: Difficult to Treat Populations
Alexandra Weiss, MD
​​
11:10 AM - 11:30 AM
MASLD: How To Diagnose With Non-Invasive Testing
Nikolaos Pyrsopoulos, MD, PhD
​​
11:30 AM - 11:50 AM
Eosinophilic Gastrointestinal Challenges
Stuart Spechler, MD
​​
​11:50 AM - 12:05 PM
Panel Discussion / Q&A
​
12:05 PM–12:35 PM
Lunch / Visit Exhibits*
​
12:35 PM - 1:20 PM
Unlocking Treatment Possibilities in PBC
Nikolaos Pyrsopoulos, MD, PhD
Industry-Sponsored Event (Non-accredited)*
Sponsored by Ipsen
​1:20 PM–1:50 PM
Break / Visit Exhibits*
​​
Session III
1:50 PM–2:10 PM
PPIs, P-CABs, H2 Blockers: Which One To Choose?
Stuart Spechler, MD
​​
2:10 PM–2:30 PM
Met-ALD: A New Kid on the Block
Ashwani Singal, MD
​
2:30 PM–2:50 PM
Alpha-1 Antitrypsin Deficiency
Jeffrey Teckman, MD
​​​​
2:50 PM–3:05 PM
Panel Discussion / Q&A
​
3:05 PM–3:20 PM
Break / Visit Exhibits*
​​
Session IV
3:20 PM–3:40 PM
Hepatorenal Syndrome: Definition, Current and Emerging Therapies
Nikolaos Pyrsopoulos, MD, PhD
​
3:40 PM–4:00 PM
Complications of Portal Hypertension
Patrick Northup, MD
​
4:00 PM–4:15 PM
Panel Discussion / Q&A
​​
Session V
4:15 PM–4:35 PM
Management of Pancreatitis in 2025
Matthew Grossman, MD
​​
4:35 PM–4:55 PM
Diagnosis and Management of Irritable Bowel Syndrome
Anthony Lembo, MD
​
4:55 PM–5:15 PM
Hepatocellular Carcinoma: Is It Declining?
Pierre Gholam, MD
​
5:15 PM - 5:30 PM
Panel Discussion / Q&A
​
5:30 PM
Conference Reception*
​
*Non-accredited session.